Charles River Laboratories International Inc
(NYSE:CRL)
$
214.2
25.52 (13.53%)
Market Cap: 10.95 Bil
Enterprise Value: 13.50 Bil
PE Ratio: 25.59
PB Ratio: 2.97
GF Score: 87/100 Charles River Laboratories International Inc at Bank of America Healthcare Conference Transcript
May 11, 2022 / 08:20PM GMT
Release Date Price:
$222.31
(-3.03%)
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
Welcome to the 2022 Bank of America Healthcare Conference. I'm Derik De Bruin, the Senior Life Sciences and Diagnostics Tools Analyst, also Biopharma Services. And thank you, everybody, for being here in beautiful Las Vegas. It's great to see so many people live and in person.
And our next company up is Charles River Labs. And with us is Birgit Girshick, Executive Vice President and COO of the organization. Thanks for being here.
Birgit Girshick
Charles River Laboratories International, Inc. - Corporate Executive VP & COO
Thank you.
Questions & Answers
Derik De Bruin
BofA Securities, Research Division - MD of Equity Research
This is the first time that you and I have actually interacted in a venue like this. So big picture question. Because I'm basically an old man, I've covered Charles River since 2003. And when I was at lab, I was certainly a research model customer, really good quality mice. It's harder to make
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot